Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.3.1.67 extracted from

  • Vlachogianni, I.C.; Fragopoulou, E.; Stamatakis, G.M.; Kostakis, I.K.; Antonopoulou, S.
    Platelet activating factor (PAF) biosynthesis is inhibited by phenolic compounds in U-937 cells under inflammatory conditions (2015), Prostaglandins Other Lipid Mediat., 121, 176-183.
    View publication on PubMed

Activating Compound

Activating Compound Comment Organism Structure
interleukin 1beta 2.5 ng/ml, induces 2fold increase in intracellular platelet activating factor levels against non-stimulated cells, as well as in the specific activity of acetyl-CoA:lyso-PAF acetyltransferase at 3 h. Effect is inhibited in presence of tyrosol or resveratrol Homo sapiens

Inhibitors

Inhibitors Comment Organism Structure
resveratrol 0.157 microM, results in 50% inhibition in interleukin 1beta effect on catalytic activity Homo sapiens
tyrosol 0.048 microM, results in 50% inhibition in interleukin 1beta effect on catalytic activity Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
U-937 cell
-
Homo sapiens
-